SK Hynix Reaches 1 Trillion Valuation Joining Micron as AI Demand Fuels Memory Chip Frenzy Barclays Raises Ross Stores Price Target After Strong Q1 Comparable Sales Growth JPMorgans 2025 Summer Reading List for Wealthy Clients Features AI Leadership and Lemons Turkish Political Turmoil Riot Police Raid Opposition Headquarters Amid Leadership Dispute USChina Trade Tensions Persist APEC Highlights Continued Divergence Spain Blocks Polymarket and Kalshi Over Missing Gambling Licenses CSGS Q1 2026 Earnings Strong EPS Beat as Earnings Surprise Exceeds 19 HPQ Q1 2026 Earnings EPS Beats Estimates as Stock Surges FMX Q1 2026 Earnings Significant EPS Miss Amidst Challenging Environment ATCH Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines on Revenue Disappointment MIST Q1 2026 Earnings Significant Earnings Miss and Stock Decline Highlight Pipeline Uncertainty BTE Q1 2026 Earnings Severe EPS Miss Highlights Operational Challenges Vicor Corporation VICR Surges 662 as Power Management Leader Breaks Above Key Levels YDKG Shows Signs of Life Yueda Digital Holding Gains 322 as Support Holds Air Lease Corporation AL Holds Steady at 65 as Key Levels Define Trading Range Insulet PODD Holds Steady Near Support as Trading Volume Remains Subdued Spartacus Acquisition Corp II Unit TMTSU Holds Steady at 1015 Amid SPAC Stability Egypt QatarEnergy ExxonMobil Partner to Route Cypriot Gas to European Markets DUK Q1 2026 Earnings Modest EPS Beat Drives Positive Market Reaction BioLineRx BLRX Surges Over 9 Biotech Stock Breaks Above Key Support Level SMR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Company Advances Technology CC Q1 2026 Earnings Chemours Surpasses Estimates with Strong EPS Surprise Teledyne Technologies TDY Q1 2026 Earnings EPS Surges Past Estimates Despite Sparse Revenue Disclosure IRS Q1 2026 Earnings Significant Loss Reported Amidst Argentine Economic Challenges ISRG Q1 2026 Earnings EPS Beat by 168 Amid Revenue Discrepancy Sprout Social Inc SPT Q1 2026 Earnings EPS Surges Past Estimates as Platform Demand Accelerates PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline